5% Lidocaine Medicated Plaster in Elderly Patients with Postherpetic Neuralgia
- 1 September 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 28 (9), 693-702
- https://doi.org/10.2165/11595600-000000000-00000
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatmentThe Lancet Neurology, 2010
- Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature UpdateMayo Clinic Proceedings, 2010
- Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term studyCurrent Medical Research and Opinion, 2009
- A Review of the Epidemiology of Painful Diabetic Peripheral Neuropathy, Postherpetic Neuralgia, and Less Commonly Studied Neuropathic Pain ConditionsPain Practice, 2008
- An Update on the Pharmacological Management of Post-Herpetic Neuralgia and Painful Diabetic NeuropathyCNS Drugs, 2008
- Herpes Zoster and Postherpetic NeuralgiaDrugs & Aging, 2008
- An evidence-based algorithm for the treatment of neuropathic pain.2007
- Safety and Tolerability of the Lidocaine Patch 5%, a Targeted Peripheral Analgesic: A Review of the LiteratureThe Journal of Clinical Pharmacology, 2003
- Characteristics of Patients with Herpes Zoster on Presentation to Practitioners in FranceClinical Infectious Diseases, 2001
- Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment studyPain, 1999